Dortmund, Germany, 30 September 2014 –Boehringer Ingelheim is investing more than €100 million at its Dortmund site to expand production capacity for the Respimat® inhaler to 44 million units per year. With this expansion, the research-driven pharmaceutical company is creating approximately 100 new jobs on site.
“The Respimat® is a success story – for Boehringer Ingelheim [...]


Home
About Us
Contact Us






